MENU
DEC 03, 2020 3:00 PM PST

Novel SARS-Cov-2 Neutralization Antibody test, performance and applications

Sponsored by: GenScript
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director, Catalog Products, GenScript USA Inc
    Biography

      Roumen Bogoev is the Director of Product Management for catalog products at GenScript. In his current role he is responsible for new product development and commercialization of life science and diagnostics products.  He has over 10 years in marketing as well as over 16 years of research and development experience. He has extensive technical expertise in the areas of immunodetection, protein purification and analysis including, chromatography, electrophoresis, mass spectrometry and other methods and techniques. Roumen is an author and co-author of number of technology patents and publications in these areas. Roumen has worked in a variety of companies including GenScript, Bio-Rad Laboratories, Life Technologies (now part of Thermo Fisher Scientific) and others. Roumen holds a Masters degree in Bioengineering.


    Abstract

    As we have all heard many times on the news, that when a COVID-19 patient gets infected they eventually develop an immune response and generate antibodies to the SARS-CoV-2 virus. However not all antibodies are created equal. Some of these antibodies simply bind to the viral proteins, while others bind in such way that they also have the ability to block the virus from infecting the cells. These antibodies are commonly referred to as neutralizing antibodies. While there are many kits on the market that detect SARS-CoV-2 binding antibodies, here we present performance data for the cPass SARS CoV-2 Neutralization Antibody Test that is FDA EUA authorized and has been shown to be equivalent to live virus tests to detect neutralizing antibodies in clinical studies. We will also share the comparison of the results to other antibody tests and discuss the differences. We will also present data on the quantitative use of the technology that can measure neutralizing antibody levels and it’s potential utility.

    Learning Objectives:

    1. Brief overview of SARS CoV-2 infection mechanism

    2. Description of cPass™ SARS-CoV-2 Neutralization Antibody Test, its advantages and comparative data with live cell neutralization and other serology tests

    3. Quantitative protocol for the Neutralization antibody test and its application to samples from recovered SARS CoV-2 patients

     


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 03, 2020 3:00 PM PST

    Novel SARS-Cov-2 Neutralization Antibody test, performance and applications

    Sponsored by: GenScript
    C.E. Credits: P.A.C.E. CE Florida CE

    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more